BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2016 4:06:00 PM | Browse: 1736 | Download: 3026
 |
Received |
|
2016-07-13 10:54 |
|
Peer-Review Started |
|
2016-07-14 17:03 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-09-09 13:58 |
|
Revised |
|
2016-10-06 11:40 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-10-13 12:17 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-10-24 15:27 |
|
Articles in Press |
|
2016-10-24 15:27 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-12-06 18:01 |
|
Publish the Manuscript Online |
|
2016-12-15 16:07 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Siddharth Sood, Lijia Yu, Kumar Visvanathan, Peter William Angus, Paul John Gow and Adam Gareth Testro |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Siddharth Sood, MBBS, BMedSci, PhD, Head of Hepatology, Department of Gastroenterology and Hepatology, University of Melbourne, Royal Melbourne Hospital, Royal Parade, Parkville, VIC 3050,
Australia. siddharth.sood@mh.org.au |
| Key Words |
Infection; Biomarker; Immune dysfunction; Immune function; Immunosuppression; Liver; Immune system; Cirrhosis; Mortality |
| Core Tip |
QuantiFERON-Monitor (QFM) is a net immune function biomarker that measures interferon-γ after stimulation of the innate and adaptive immune systems and is based on a readily available pathology platform. Measuring QFM in cirrhotic patients provides an objective marker of their immune dysfunction, which has otherwise been difficult to quantify. Low QFM is significantly associated with the risk of pre-transplant infection, and very low QFM may be associated with increased risk of mortality. |
| Publish Date |
2016-12-15 16:07 |
| Citation |
Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol 2016; 8(35): 1569-1575
|
| URL |
http://www.wjgnet.com/1948-5182/full/v8/i35/1569.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v8.i35.1569 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
